Liste d'autorisations

Liste d'autorisations

Liste d'autorisations

List of substances included in Annex XIV of REACH ("Authorisation List").
 
 

 

Notes to the Authorisation List

The following notes are inserted for the entries 4 - 7, 10 - 12, 14 - 23, 25 and 27 - 46:

  1. in ‘Latest application date’ column:
    1 September 2021 for the use of the substance in the production of spare parts as articles or as complex products for the repair of articles or complex products, the production of which ceased or will have ceased before the sunset date indicated in the entry for that substance, where that substance was used in the production of those articles or complex products and these cannot function as intended without that spare part and the spare part cannot be produced without that substance, and for the use of the substance (on its own or in a mixture) for the repair of such articles or complex products where that substance on its own or in a mixture was used in the production of those articles or complex products and they cannot be repaired otherwise than by using that substance.
  2. in ‘Sunset date’ column:
    1 March 2023 for the use of the substance in the production of spare parts as articles or as complex products for the repair of articles or complex products the production of which ceased or will have ceased before the sunset date indicated in the entry for that substance, where that substance was used in the production of those articles or complex products and these cannot function as intended without those spare parts and the spare part cannot be produced without that substance, and for the use of the substance (on its own or in a mixture) for the repair of such articles or complex products, where that substance on its own or in a mixture was used in the production of those articles or complex products and they cannot be repaired otherwise than by using that substance.

The following notes are inserted for the entry 40:

  1. does not meet the criteria for identification as a carcinogen if it contains < 0,005 % (w/w) benzo[a]pyrene (Einecs No 200-028-5)

The following notes are inserted for the entry 42:

  1. in ‘Latest application date’ column:
    22 June 2022 for uses as follows:
    • for the research, development and production of medicinal products falling within the scope of Directive 2001/83/EC or medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746 of the European Parliament and of the Council (Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176)), in view of their use for the diagnosis, treatment or prevention of the coronavirus disease (COVID-19),
    • in medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746, for the diagnosis, treatment or prevention of COVID-19.
  2. in ‘Sunset date’ column:
    22 December 2023 for uses as follows:
    • for the research, development and production of medicinal products falling within the scope of Directive 2001/83/EC or medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746, in view of their use for the diagnosis, treatment or prevention of COVID-19,
    • in medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746, for the diagnosis, treatment or prevention of COVID-19.

 

4,4’- Diaminodiphenylmethane (MDA)

EC No.: 202-974-4 CAS No.: 101-77-9
Entry No.
02
Sunset Date
21/08/2014
Latest application date
21/02/2013
Exempted (categories of) uses
Intrinsic property(ies) referred to in Article 57
Carcinogenic (Article 57a)
Review Periods
Remarks

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.